| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |